FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Sonlicromanol, 1541170-75-5, Sonlicromanol Intermediate 53174-06-4, stock 799.4g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply.
Sonlicromanol, 1541170-75-5, Sonlicromanol Intermediate 188111-79-7, stock 814.9g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply.
Sonlicromanol, 1541170-75-5, Sonlicromanol Intermediate 1541170-76-6, stock 940g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply.
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Sonlicromanol, 1541170-75-5, Sonlicromanol Intermediate 53174-06-4, stock 799.4g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply.
Sonlicromanol, 1541170-75-5, Sonlicromanol Intermediate 188111-79-7, stock 814.9g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply.
Sonlicromanol, 1541170-75-5, Sonlicromanol Intermediate 1541170-76-6, stock 940g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply.